4595 Stock Overview
Mizuho Medy Co.,Ltd. researches and develops, manufactures, and sells in-vitro diagnostic products and related scientific and technical information services primarily in Japan.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Mizuho Medy Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥3,275.00 |
| 52 Week High | JP¥3,890.00 |
| 52 Week Low | JP¥2,010.00 |
| Beta | 1.06 |
| 1 Month Change | 0% |
| 3 Month Change | -6.96% |
| 1 Year Change | 48.06% |
| 3 Year Change | -14.49% |
| 5 Year Change | 12.93% |
| Change since IPO | 629.40% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4595 | JP Medical Equipment | JP Market | |
|---|---|---|---|
| 7D | -4.2% | 0.5% | -2.2% |
| 1Y | 48.1% | 10.2% | 29.7% |
Return vs Industry: 4595 exceeded the JP Medical Equipment industry which returned 10.2% over the past year.
Return vs Market: 4595 exceeded the JP Market which returned 29.7% over the past year.
Price Volatility
| 4595 volatility | |
|---|---|
| 4595 Average Weekly Movement | 4.7% |
| Medical Equipment Industry Average Movement | 3.9% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in JP Market | 8.3% |
| 10% least volatile stocks in JP Market | 2.2% |
Stable Share Price: 4595 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4595's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1977 | 180 | Fuminari Karakawa | www.mizuho-m.co.jp |
Mizuho Medy Co.,Ltd. researches and develops, manufactures, and sells in-vitro diagnostic products and related scientific and technical information services primarily in Japan. The company provides immunoassay test products, such as influenza virus kits; RS virus and human metapneumovirus antigen test kits; streptococcus pneumoniae antigen and legionella antigen test kits; mycoplasma pneumoniae antigen test kits; adenovirus antigen test kits; rotavirus and adenovirus antigen test kits; norovirus antigen test kits; group a streptococcal antigen test kits; pregnancy test kits; ovulation test kits; and fecal occult blood test kits.
Mizuho Medy Co.,Ltd. Fundamentals Summary
| 4595 fundamental statistics | |
|---|---|
| Market cap | JP¥31.62b |
| Earnings (TTM) | JP¥3.77b |
| Revenue (TTM) | JP¥10.99b |
8.3x
P/E Ratio2.8x
P/S RatioIs 4595 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4595 income statement (TTM) | |
|---|---|
| Revenue | JP¥10.99b |
| Cost of Revenue | JP¥2.92b |
| Gross Profit | JP¥8.07b |
| Other Expenses | JP¥4.30b |
| Earnings | JP¥3.77b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 10, 2024
| Earnings per share (EPS) | 396.24 |
| Gross Margin | 73.47% |
| Net Profit Margin | 34.34% |
| Debt/Equity Ratio | 0% |
How did 4595 perform over the long term?
See historical performance and comparison